[go: up one dir, main page]

AR041936A1 - Formulacion micelar acuosa que comprende un primer agente activo seleccionado de bencimidazoles insolubles en agua, salicilanilidas y derivados activos o sales de los mismos en combinacion con un segundo agente activo seleccionado de lactonas macrociclicas o derivados activos o sales de las mismas y - Google Patents

Formulacion micelar acuosa que comprende un primer agente activo seleccionado de bencimidazoles insolubles en agua, salicilanilidas y derivados activos o sales de los mismos en combinacion con un segundo agente activo seleccionado de lactonas macrociclicas o derivados activos o sales de las mismas y

Info

Publication number
AR041936A1
AR041936A1 ARP030104139A ARP030104139A AR041936A1 AR 041936 A1 AR041936 A1 AR 041936A1 AR P030104139 A ARP030104139 A AR P030104139A AR P030104139 A ARP030104139 A AR P030104139A AR 041936 A1 AR041936 A1 AR 041936A1
Authority
AR
Argentina
Prior art keywords
agent selected
derivatives
active agent
active
water
Prior art date
Application number
ARP030104139A
Other languages
English (en)
Original Assignee
Schering Plough Pty Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Schering Plough Pty Ltd filed Critical Schering Plough Pty Ltd
Publication of AR041936A1 publication Critical patent/AR041936A1/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
    • A61K31/167—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide having the nitrogen of a carboxamide group directly attached to the aromatic ring, e.g. lidocaine, paracetamol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/365—Lactones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/4164—1,3-Diazoles
    • A61K31/4184—1,3-Diazoles condensed with carbocyclic rings, e.g. benzimidazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
    • A61K31/7048—Compounds having saccharide radicals and heterocyclic rings having oxygen as a ring hetero atom, e.g. leucoglucosan, hesperidin, erythromycin, nystatin, digitoxin or digoxin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A61K9/0017—Non-human animal skin, e.g. pour-on, spot-on
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/107—Emulsions ; Emulsion preconcentrates; Micelles
    • A61K9/1075—Microemulsions or submicron emulsions; Preconcentrates or solids thereof; Micelles, e.g. made of phospholipids or block copolymers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A61P33/10—Anthelmintics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A61P33/14—Ectoparasiticides, e.g. scabicides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Dermatology (AREA)
  • Molecular Biology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Zoology (AREA)
  • Biophysics (AREA)
  • Dispersion Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Pain & Pain Management (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

Formulaciones micerales acuosas para la administración tópica de bencimidazoles o salicilanilidas con lactonas macrocíclicas a ganado para el control de endo y ectoparásitos, las cuales comprenden un primer agente activo seleccionado de bencimidazoles insolubles en agua, salicilanilidas y derivados activos o sales del mismo, en combinación con un segundo agente activo seleccionado de lactonas macrocíclicas o derivados activos o sales de las mismas, y también comprende, por litro de formulación: alrededor de 100g a 400g de surfactante(s); alrededor de 200g a 750g de solvente(s)miscible(s} en agua aceptable(s) desde el punto de vista veterinario; y alrededor de 50g a 350g de agua. Las formulaciones propuestas son de utilidad para su administración al ganado en forma dosificada para controlar y/o prevenir enfermedades o infecciones parasitarias en el mismo.
ARP030104139A 2002-11-11 2003-11-11 Formulacion micelar acuosa que comprende un primer agente activo seleccionado de bencimidazoles insolubles en agua, salicilanilidas y derivados activos o sales de los mismos en combinacion con un segundo agente activo seleccionado de lactonas macrociclicas o derivados activos o sales de las mismas y AR041936A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
AU2002952597A AU2002952597A0 (en) 2002-11-11 2002-11-11 Topical parasiticide formulations and methods of treatment

Publications (1)

Publication Number Publication Date
AR041936A1 true AR041936A1 (es) 2005-06-01

Family

ID=28795986

Family Applications (1)

Application Number Title Priority Date Filing Date
ARP030104139A AR041936A1 (es) 2002-11-11 2003-11-11 Formulacion micelar acuosa que comprende un primer agente activo seleccionado de bencimidazoles insolubles en agua, salicilanilidas y derivados activos o sales de los mismos en combinacion con un segundo agente activo seleccionado de lactonas macrociclicas o derivados activos o sales de las mismas y

Country Status (14)

Country Link
US (1) US20060121072A1 (es)
EP (1) EP1560572A4 (es)
JP (3) JP4643990B2 (es)
KR (1) KR20050090385A (es)
AR (1) AR041936A1 (es)
AU (1) AU2002952597A0 (es)
BR (1) BR0316187A (es)
CA (1) CA2504197A1 (es)
MX (1) MXPA05005046A (es)
NZ (1) NZ540589A (es)
PE (1) PE20040545A1 (es)
TW (1) TWI314848B (es)
WO (1) WO2004043445A1 (es)
ZA (1) ZA200503758B (es)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2002952597A0 (en) * 2002-11-11 2002-11-28 Schering-Plough Pty. Limited Topical parasiticide formulations and methods of treatment
GB0316377D0 (en) * 2003-07-12 2003-08-13 Norbrook Lab Ltd Parasiticidal composition
US7666444B2 (en) 2004-02-02 2010-02-23 Wyeth Antiparasitic composition
DK1713468T3 (da) * 2004-02-03 2010-08-16 Wyeth Llc Anthelmintisk sammensætning
CN100496246C (zh) * 2004-06-07 2009-06-10 辛根塔参与股份公司 减轻线虫损害的方法
WO2006061214A1 (en) * 2004-12-10 2006-06-15 Bayer Healthcare Ag Anthelmintic composition
KR101233488B1 (ko) 2005-09-15 2013-02-14 메리얼 리미티드 구충 제형
CA2630458C (en) * 2005-12-06 2014-10-28 Wyeth Benzimidazole non-aqueous compositions
GB2451811A (en) 2007-08-09 2009-02-18 Ems Sa Delivery composition for solubilising water-insoluble pharmaceutical active ingredients
BRPI0819849B8 (pt) * 2007-11-26 2021-05-25 Merial Ltd sistemas de solvente para formulações pour on para combater parasitas
AU2013201461B2 (en) * 2007-11-26 2015-10-29 Boehringer Ingelheim Animal Health USA Inc. Solvent systems for pour-on formulations for combating parasites
CA2737102C (en) * 2008-10-08 2014-02-18 Wyeth Llc Benzimidazole anthelmintic compositions
US20120196821A1 (en) * 2009-10-19 2012-08-02 Roger Mervyn Sargent Method and formulation for the control of parasites
WO2011143479A1 (en) * 2010-05-12 2011-11-17 Merial Limited Injectable parasiticidal formulations of levamisole and macrocyclic lactones
US11166912B2 (en) 2016-03-03 2021-11-09 Ctt Pharma Inc. Orally administrable composition
KR101855989B1 (ko) 2016-12-23 2018-05-09 강원대학교산학협력단 가용화제를 첨가한 물을 추출용매로 이용한 유용성분이 증가된 메밀 종자 추출물의 제조 방법 및 그에 따른 메밀 종자 추출물
US11298336B2 (en) 2019-05-30 2022-04-12 Soluble Technologies, Inc. Water soluble formulation
US11786475B2 (en) 2020-07-22 2023-10-17 Soluble Technologies Inc. Film-based dosage form

Family Cites Families (37)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3914418A (en) * 1971-09-02 1975-10-21 Merck & Co Inc Methods of controlling liver fluke infections
US3927071A (en) * 1972-05-12 1975-12-16 Ici Australia Ltd Salicylanilides
US3989826A (en) * 1972-05-12 1976-11-02 Ici Australia Limited Method of killing internal parasites using salicylanilides
US3950360A (en) * 1972-06-08 1976-04-13 Sankyo Company Limited Antibiotic substances
US4336262A (en) * 1973-02-23 1982-06-22 Fisons Ltd. Pour-on veterinary anthelmintic
GB1493375A (en) * 1974-09-20 1977-11-30 Ici Ltd Salicylanilide derivatives
US4005218A (en) * 1975-03-18 1977-01-25 Janssen Pharmaceutica N.V. Antiparasitic salicylanilide derivatives
DE3029426A1 (de) * 1980-08-02 1982-03-11 Bayer Ag, 5090 Leverkusen Gegen zwecken wirksame pour-on-formulierungen
US4389397A (en) * 1980-08-04 1983-06-21 Merck & Co., Inc. Solubilization of ivermectin in water
OA06863A (fr) * 1980-08-04 1983-02-28 Merck & Co Inc Solubilisation de l'invermectine dans l'eau.
US4607050A (en) * 1981-10-19 1986-08-19 Wellcome Australia Limited Method of controlling insects and parasites with an aqueous localized pour-on formulation
GB2117638B (en) * 1982-03-16 1986-10-29 Wellcome Australia Pour-on formulation
EP0179583A1 (en) * 1984-10-04 1986-04-30 Merck & Co. Inc. A system for enhancing the water dissolution rate and solubility of poorly soluble drugs
GB8723347D0 (en) * 1987-10-05 1987-11-11 Shell Int Research Ectoparasiticidal pour-on formulation
US5639949A (en) * 1990-08-20 1997-06-17 Ciba-Geigy Corporation Genes for the synthesis of antipathogenic substances
NZ335166A (en) * 1999-04-14 2001-11-30 Ashmont Holdings Ltd Anthelmintic composition containing triclabendazole in at least one solvent
US5602107A (en) * 1993-05-10 1997-02-11 Merck & Co., Inc. Pour-on formulations consisting of gylcols, glycerides and avermectin compounds
PL174488B1 (pl) * 1993-05-10 1998-08-31 Merck & Co Inc Preparat do zwalczania pasożytów zwierząt oraz sposób wytwarzania preparatu do zwalczania pasożytów zwierząt
EP0705101B1 (en) * 1993-05-26 2001-12-19 Commonwealth Scientific And Industrial Research Organisation Antiparasitic compositions
DK72593D0 (da) * 1993-06-18 1993-06-18 Symbicom Ab Rekombinant protein
NZ260018A (en) * 1994-03-03 1995-10-26 Bomac Lab Ltd Benzimidazole compositions and anthelmintic compositions
US6010710A (en) * 1996-03-29 2000-01-04 Merial Direct pour-on skin solution for antiparasitic use in cattle and sheep
FR2755824B1 (fr) * 1996-11-19 1999-01-08 Virbac Sa Formulation galenique des benzimidazoles a usage topique, son procede de preparation et ses utilisations
CN1069032C (zh) * 1997-03-27 2001-08-01 中国农业大学 一种含阿维菌素/依维菌素的兽用抗寄生虫药
US5968990A (en) * 1997-10-14 1999-10-19 Isp Investments Inc. Water-dilutable, microemulsion concentrate and pour-on formulations thereof
AUPP105497A0 (en) * 1997-12-19 1998-01-15 Schering-Plough Animal Health Limited Aqueous insecticidal pour-on treatment
CN1214909A (zh) * 1998-05-14 1999-04-28 王玉万 一种复方兽用抗寄生虫药
US6103248A (en) * 1998-05-22 2000-08-15 Burkhart; Craig G. Topical preparation and therapy for head lice
DK1154759T3 (da) * 1998-12-30 2008-12-08 Dexcel Ltd Dispergerbart koncentrat til indgift af cyclosporin
DE60025198D1 (de) * 1999-06-04 2006-02-02 Nufarm Ltd Stabile biozidale zusammensetzung
US6340672B1 (en) * 2000-02-16 2002-01-22 Phoenix Scientific, Inc. Parasiticidal formulation and a method of making this formulation
US6787342B2 (en) * 2000-02-16 2004-09-07 Merial Limited Paste formulations
EP1129713A1 (en) * 2000-02-29 2001-09-05 New Pharma Research Sweden AB Veterinary compositions for the treatment of parasitic diseases
GB2386066A (en) * 2002-02-28 2003-09-10 Norbrook Lab Ltd Long-acting parasiticidal composition with improved bioavailability comprising a salicylanilide, a further anti-parasitic compound & a polymeric species
AU2002952597A0 (en) * 2002-11-11 2002-11-28 Schering-Plough Pty. Limited Topical parasiticide formulations and methods of treatment
NZ523128A (en) * 2002-12-12 2006-01-27 Ashmont Holdings Ltd Anthelmintic formulations containing avermectins and or milbemycins
GB0316377D0 (en) * 2003-07-12 2003-08-13 Norbrook Lab Ltd Parasiticidal composition

Also Published As

Publication number Publication date
WO2004043445A1 (en) 2004-05-27
PE20040545A1 (es) 2004-08-28
TWI314848B (en) 2009-09-21
MXPA05005046A (es) 2005-11-17
JP2006508108A (ja) 2006-03-09
JP4643990B2 (ja) 2011-03-02
JP2011105765A (ja) 2011-06-02
EP1560572A4 (en) 2011-05-04
US20060121072A1 (en) 2006-06-08
JP2007008963A (ja) 2007-01-18
CA2504197A1 (en) 2004-05-27
NZ540589A (en) 2008-03-28
BR0316187A (pt) 2005-09-27
AU2002952597A0 (en) 2002-11-28
ZA200503758B (en) 2006-11-29
EP1560572A1 (en) 2005-08-10
KR20050090385A (ko) 2005-09-13
TW200423871A (en) 2004-11-16

Similar Documents

Publication Publication Date Title
AR041936A1 (es) Formulacion micelar acuosa que comprende un primer agente activo seleccionado de bencimidazoles insolubles en agua, salicilanilidas y derivados activos o sales de los mismos en combinacion con un segundo agente activo seleccionado de lactonas macrociclicas o derivados activos o sales de las mismas y
PA8509001A1 (es) Forma de dosificacion de farmacos accionada por un hidrogel
CY1120462T1 (el) Τοπικες ανθελμινθικες κτηνιατρικες τυποποιησεις
DK1582204T3 (da) Echinocandin-farmaceutiske formuleringer, der indeholder miceldannende overfladeaktive stoffer
AR038535A1 (es) Formulaciones farmaceuticas de agentes antineoplasicos y procesos para prepararlos y usarlos
MXPA01003182A (es) Sistema de liberacion controlada de agentes antifungicos y queratoliticos para el tratamiento local de las infecciones fungicas de la una y los tejidos circundantes.
ES2094688B1 (es) Manoemulsion del tipo de aceite en agua, util como vehiculo oftalmico y procedimiento para su preparacion.
AR056808A1 (es) Formulacion de aceite en agua de avermectinas
AR039722A1 (es) Pastas veterinarias antihelminticas orales homogeneas
AR037018A1 (es) Formulaciones plaguicidas
AR055363A1 (es) Formulaciones farmaceuticas que comprenden un beta 2- agonista de accion prolongada para administracion por nebulizacion
CR7140A (es) Antranilamidas con una cadena colateral de un heteroarylsulfonil, metodos para la produccion de los mismos, su uso como medicamento o agente diagnostico y preparaciones farmaceuticas contenidas en dichos compuestos
CO6270298A2 (es) Composiciones para el cuidado del cabello/cuero cabelludo que comprende un surfactante y una mezcla eutecnica
AR034370A1 (es) Una preparacion farmaceutica acuosa de cilostazol para uso parenteral
AR065316A1 (es) Uso de quitosanos, derivados de quitosanos y una sal fisiologiamente aceptable del mismo para el tratamiento de enfermedades inflamatorias ungueales
BR112023019201A2 (pt) Composição farmacêutica aquosa ou composição farmacêutica liofilizada
MX2007011039A (es) Sistema de solvente para aumentar la solubilidad de agentes farmaceuticos.
JP2006508108A5 (es)
AR031649A1 (es) Composicion farmaceutica de dronedarona para administracion parenteral
AR079409A1 (es) Preparaciones antihelminticas granuladas y sistemas de suninistros
AR057319A1 (es) Composicion para la administracion topica y metodo para evitar o tratar infeccion o infestacion endoparasitica y ectoparasitica en un animal de sangre caliente
ES2846820T3 (es) Composición de lactonas macrocíclicas, levamisol, un aminoazúcar y un agente antiparasitario adicional
AR046146A1 (es) Formulaciones farmaceuticas transdermicas para pulverizacion que comprenden un agente activo, un copolimero de vp/va y un vehiculo no acuoso
PE117199A1 (es) Formulaciones parasiticidas
ES2197781B1 (es) Composiciones farmaceuticas liquidas de base acuosa en forma de suspension para la administracion por via oral de ibuprofeno.

Legal Events

Date Code Title Description
FA Abandonment or withdrawal